AR058701A1 - Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos - Google Patents

Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos

Info

Publication number
AR058701A1
AR058701A1 ARP060105669A ARP060105669A AR058701A1 AR 058701 A1 AR058701 A1 AR 058701A1 AR P060105669 A ARP060105669 A AR P060105669A AR P060105669 A ARP060105669 A AR P060105669A AR 058701 A1 AR058701 A1 AR 058701A1
Authority
AR
Argentina
Prior art keywords
substituted
unsubstituted
independently
alkyl
moc
Prior art date
Application number
ARP060105669A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR058701(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR058701A1 publication Critical patent/AR058701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP060105669A 2005-12-22 2006-12-20 Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos AR058701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
AR058701A1 true AR058701A1 (es) 2008-02-20

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105669A AR058701A1 (es) 2005-12-22 2006-12-20 Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos

Country Status (12)

Country Link
US (2) US7557100B2 (https=)
EP (2) EP1971612A1 (https=)
JP (1) JP5513743B2 (https=)
AR (1) AR058701A1 (https=)
CA (1) CA2634644A1 (https=)
DO (1) DOP2006000268A (https=)
GT (1) GT200600520A (https=)
NL (1) NL2000373C2 (https=)
PE (1) PE20071137A1 (https=)
TW (1) TW200734344A (https=)
UY (1) UY30030A1 (https=)
WO (1) WO2007072151A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
US20100261719A1 (en) * 2007-07-02 2010-10-14 Gregory Steven Basarab Chemical compounds
CA2729923A1 (en) * 2007-07-06 2009-01-15 Aarhus Universitet Dehydrated chitosan nanoparticles
CN101687871A (zh) 2007-07-16 2010-03-31 阿斯利康(瑞典)有限公司 用作抗菌剂的螺缩合巴比妥酸衍生物
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
CN102245605B (zh) * 2008-10-14 2016-01-27 阿斯利康(瑞典)有限公司 用于治疗细菌感染的稠合、螺环杂芳族化合物
AU2009308182B2 (en) * 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
SG10201906842WA (en) 2014-05-29 2019-08-27 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
KR102717819B1 (ko) 2017-07-28 2024-10-14 다케다 야쿠힌 고교 가부시키가이샤 Tyk2 억제제 및 이의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CN1501937A (zh) 2000-10-26 2004-06-02 �Ʒ� 螺-嘧啶-2,4,6-三酮金属蛋白酶抑制剂
ATE315038T1 (de) * 2001-05-30 2006-02-15 Warner Lambert Co Antibakterielle mittel
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
UY30030A1 (es) 2007-07-31
NL2000373A1 (nl) 2007-06-26
CA2634644A1 (en) 2007-06-28
US20090275536A1 (en) 2009-11-05
US7557100B2 (en) 2009-07-07
GT200600520A (es) 2007-07-17
TW200734344A (en) 2007-09-16
NL2000373C2 (nl) 2010-02-02
US20070197518A1 (en) 2007-08-23
DOP2006000268A (es) 2007-07-31
WO2007072151A1 (en) 2007-06-28
JP5513743B2 (ja) 2014-06-04
PE20071137A1 (es) 2008-01-10
JP2009520804A (ja) 2009-05-28
EP1971612A1 (en) 2008-09-24
EP2620439A1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AR047098A1 (es) Derivados de arilanilina como agonistas del receptor adrenergico beta2
CY1121231T1 (el) Παραγωγο τετραϋδροϊμιδαζο[1,5-d][1,4]οξαζεπινης
BRPI0512615A (pt) compostos de sulfonamida
AR058546A1 (es) Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
UY30499A1 (es) Derivados de amina utiles como agentes anticancerigenos
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
EP1724262A4 (en) 1- (2H) -ISOCHINOLONDERIVAT
ES2721268T3 (es) Compuestos de pirazolo[1,5-a]pirimidina-5,7-diamina como inhibidores de CDK y su uso terapéutico
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
AR064197A1 (es) Derivados de pirimidina y piridina inhibidores de la proteina quinasa
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
CO6190626A2 (es) Compuestos y composiciones como inhibidores de proteasa activadora de canal
AR065863A1 (es) Derivados de imidazolidinona
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
UY30897A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
PH12014500831A1 (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate

Legal Events

Date Code Title Description
FB Suspension of granting procedure